Olympus Corporation (OCPNF)

13,95 -0,16 (-1,13%) Alla chiusura: 09:36AM EDT

Olympus Corporation

Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo 163-0914
Japan
81 3 3340 2111
https://www.olympus-global.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 32.844

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Yasuo Takeuchi	Representative Executive Officer, ESG Officer & Executive Chairman	2,46M	N/D	1957
Mr. Andre Roggan	Executive Officer & CTO	1,48M	N/D	N/D
Stephen Kneebone	Corporate Officer & Chief Information Officer	4,72M	N/D	N/D
Mr. Stefan Kaufmann	Representative Executive Officer, President, CEO & Director	4,25M	N/D	1968
Izumi Tatsuya	Executive Officer & Chief Financial Officer	N/D	N/D	1964
Takaaki Sakurai	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Donna Miller	Head of HQ Legal and Global General Counsel	N/D	N/D	N/D
Shigeto Ohtsuki	Executive Officer & Chief Human Resources Officer	N/D	N/D	N/D
Mr. Tetsuo Kobayashi	Executive Officer and Chief Manufacturing & Supply Officer	N/D	N/D	N/D
Hidenao Tsuchiya	Corporate Officer , Regional Representative Officer of China & Chairman, Olympus (China) Co., Ltd.	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Governance aziendale

L'ISS Governance QualityScore di Olympus Corporation al 1 aprile 2024 è 1. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 1; diritti degli azionisti: 5; retribuzione: 1.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.